People · Operator

Robert Crockett

Named in public records as an officer, director or promoter · active 2016–2018 · Software / Tech, Healthtech

2
Companies
2
Filings
$9.2M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
I-V Access Technology, Inc.Software / TechSeed$7.5M$73.4M2016
CoLabs Medical, Inc.HealthtechSeed$1.8M$49.4M2018
Operator network

Robert Crockett at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Brian Miller · 14 companies · 1 sharedBrian MillerJim Hale · 2 companies · 1 sharedJim HaleMichael Salucci · 2 companies · 1 sharedMichael SalucciMike Salucci · 2 companies · 1 sharedMike SalucciDarryl Fry · 1 companies · 1 sharedDarryl FryDwight Miller · 1 companies · 1 sharedDwight MillerGerard Frigon · 1 companies · 1 sharedGerard FrigonGerry Frigon · 1 companies · 1 sharedGerry FrigonThomas Rocca · 1 companies · 1 sharedThomas RoccaTom Rocca · 1 companies · 1 sharedTom RoccaChris Baker · 7 companies · 1 sharedChris BakerMichael D. Laufer · 2 companies · 1 sharedMichael D. LauferBob D. Mellen · 1 companies · 1 sharedBob D. MellenClay Nolan · 1 companies · 1 sharedClay NolanI-V Access Technology, Inc. · $7.5M raisedI-V Access Technology…CoLabs Medical, Inc. · $1.8M raisedCoLabs Medical, Inc.Robert CrockettRC
Robert Crockett Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Robert Crockett on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Brian Miller114
Chris Baker17
Jim Hale12
Michael Salucci12
Michael D. Laufer12
Mike Salucci12
Darryl Fry11
Bob D. Mellen11
Clay Nolan11
Dwight Miller11
Gerard Frigon11
Gerry Frigon11
Thomas Rocca11
Tom Rocca11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.